Search results
Results from the WOW.Com Content Network
In 2013, trastuzumab emtansine was approved in the United States for the treatment of adults with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination. [18] [20] Referred to as T-DM1 during clinical research, trastuzumab emtansine was reviewed under the FDA's priority review ...
The Washington Post submitted a complaint against Coler's registration of the site with GoDaddy under the UDRP, and in 2015, an arbitral panel ruled that Coler's registration of the domain name was a form of bad-faith cybersquatting (specifically, typosquatting), "through a website that competes with Complainant through the use of fake news ...
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. [ 31 ] [ 28 ] [ 32 ] [ 33 ] It is specifically used for cancer that is HER2 receptor positive . [ 31 ]
We want AOL users to enjoy their time on our platform, and we provide various tools and standards to allow you to make the most of your experience. If you encounter abusive or inappropriate conduct by others on AOL, we encourage you to report the offense so we can ensure that action is taken. Unsolicited Bulk Email (Spam)
The call center employed 50-70 people to lead an “aggressive” telemarketing campaign, court records show. Florida call center manager bamboozled doctors in $67 million Medicare scam, jury says ...
Trastuzumab deruxtecan is indicated for the treatment of adults with unresectable (unable to be removed with surgery) or metastatic (when cancer cells spread to other parts of the body) HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting and for adults with locally advanced or metastatic HER2-positive gastric or gastroesophageal ...
The U.S. Office of Special Counsel (OSC) has ordered the Department of Agriculture to investigate worker complaints about poor management and safety hazards at its flagship Maryland research ...
Here are links to possibly useful sources of information about Trastuzumab. PubMed provides review articles from the past five years (limit to free review articles) The TRIP database provides clinical publications about evidence-based medicine. Other potential sources include: Centre for Reviews and Dissemination and CDC